The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The Peptide Boom Is Getting Out of Hand The Atlantic The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype BPC 157 and Erectile Dysfunction: What the Evidence Actually Shows